Pre-order Enquiry
Request Free Sample
Global Sacral Nerve Stimulation Devices Market Professional Survey Report 2019
SKU ID : QYR-14651226 | Publishing Date : 04-Sep-2019 | No. of pages : 119
Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor.
The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is completely new to the market in APAC as implantable SNS devices are more popular compared with external SNS devices. With the introduction of new SNS devices by companies such as Nuvectra and Axonics Modulation Technologies, this segment is anticipated to have a positive outlook in the coming years.
The hospitals segment was the highest revenue contributing segment in the sacral nerve stimulation market. The complexity of the device, the need for technical expertise, and high procedure cost are some of the factors that will promote the increased adoption of SNS devices in hospitals.
The global Sacral Nerve Stimulation Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Sacral Nerve Stimulation Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sacral Nerve Stimulation Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Sacral Nerve Stimulation Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Sacral Nerve Stimulation Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Medtronic
Boston Scientific
St. Jude Medical
Axonics Modulation Technologies
Nuvectra
Cogentix Medical
Cyberonics
Uroplasty, Inc
Neuropace
IntraPace, Inc
Codman & Shurtleff, Inc
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Implantable SNS Devices
External SNS Devices
Segment by Application
Hospitals
Clinics
ASCs
The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is completely new to the market in APAC as implantable SNS devices are more popular compared with external SNS devices. With the introduction of new SNS devices by companies such as Nuvectra and Axonics Modulation Technologies, this segment is anticipated to have a positive outlook in the coming years.
The hospitals segment was the highest revenue contributing segment in the sacral nerve stimulation market. The complexity of the device, the need for technical expertise, and high procedure cost are some of the factors that will promote the increased adoption of SNS devices in hospitals.
The global Sacral Nerve Stimulation Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Sacral Nerve Stimulation Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sacral Nerve Stimulation Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Sacral Nerve Stimulation Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Sacral Nerve Stimulation Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Medtronic
Boston Scientific
St. Jude Medical
Axonics Modulation Technologies
Nuvectra
Cogentix Medical
Cyberonics
Uroplasty, Inc
Neuropace
IntraPace, Inc
Codman & Shurtleff, Inc
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Implantable SNS Devices
External SNS Devices
Segment by Application
Hospitals
Clinics
ASCs
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
